Small Acceptance Rate

Wiley's current Small journal page lists three useful planning metrics: 31% acceptance rate, 16.8 CiteScore, and 12.1 JIF. Use the 31% figure as a journal-level benchmark, not as a forecast for an individual paper.

What is stable is the journal model:

• the journal is centered on micro- and nanoscale science

• the length scale has to be scientifically important, not decorative

• editors want functional consequence, not just characterization

• the paper has to look like a real Small paper, not a broader materials paper with nano branding

That is the planning surface authors should actually use once they know the headline rate.

The acceptance rate should be read alongside citation and scope signals, because Small is a high-volume, broad nanoscience journal rather than a narrow specialist title.

Historical JIF data show a rise through 2021, then a softer but still high 2024 value. The 2024 figure is down from 13.0 in 2023 and 13.3 in 2022, but still up from 9.598 in 2017.

The practical read: Small is not becoming easy just because the listed acceptance rate is 31%. It remains selective because editors still need a manuscript to show nanoscale consequence, functional value, and a credible evidence package.

Evidence basis. How this page was researched: we checked Wiley's current Small journal metrics and author guidance, cross-checked the JCR-history trend against BioxBio, checked SCImago for category context, and reviewed recent Small article examples for the kinds of nano- and microscale claims the journal is publishing now. In our pre-submission review work, we find the same recurring risk pattern: authors treat the rate as the decision surface, while editors specifically screen whether the nanoscale feature is the scientific contribution.

Small is usually asking:

• does the micro- or nanoscale dimension genuinely drive the result?

• is the functional demonstration strong enough to justify the claims?

• are characterization, controls, and comparisons credible?

• does the paper fit Small rather than a stronger flagship or a weaker broad-scope materials title?

Those are the questions that matter more than the percentage alone.

For Small, the useful question is:

Does the manuscript show a real micro- or nanoscale effect with enough functional value and evidence quality to deserve a Small audience?

If yes, the journal is plausible. If no, the acceptance-rate discussion is mostly noise.

In our pre-submission review work with Small-targeted manuscripts, the common misses are:

• centering strategy around an unofficial percentage

• assuming any nano-labeled work automatically fits

• overvaluing synthesis novelty when the function story is still thin

• treating Small as a fallback without checking whether the journal identity really matches the paper

Those are fit problems before they are rate problems.

If you are deciding whether to submit, pair the 31% metric with pages that test the actual fit question:

• is my paper ready for Small

• Small vs Nano Letters

• Advanced Functional Materials acceptance-rate context

• how to choose a journal for your paper

Together, they tell you whether size really matters in the story, whether the function package is strong enough, and whether another nano or materials journal would be cleaner.

The honest answer to "what is the Small acceptance rate?" is that Wiley currently lists 31%.

The useful answer is:

• yes, the journal is selective

• no, the percentage is not the right planning tool by itself

• use nanoscale consequence, function, and journal identity instead

If you want help deciding whether this manuscript really belongs in Small before submission, a Small nanoscale consequence and scope fit check is the best next step.

For manuscripts targeting Small, three failure modes show up in most desk-rejection outcomes. Each reflects the journal's standard: genuine nano- or microscale effect, strong functional demonstration, and an evidence package that supports the claims.

Nano label without size-dependent effect. The failure pattern is a paper where nanoparticles, nanosheets, or nanostructures appear in the title and abstract, but the experimental design does not compare size-dependent behavior to a bulk or non-nano control.

Small editors evaluate whether the micro- or nanoscale dimension is scientifically important or incidentally present. A paper synthesizing silver nanoparticles and testing antimicrobial activity against bacterial strains, without comparing size-dependent activity versus bulk silver or larger particles, is using nano as a descriptor rather than as a scientific variable. During triage, the editor asks whether the story changes if you remove the nano prefix. If the answer is no, the paper does not clear the desk.

Characterization paper without functional demonstration. The failure pattern is a paper presenting a new synthesis route, a novel nanostructure morphology, or an improved fabrication process with thorough characterization (TEM, XRD, BET, FTIR) but without a functional outcome that demonstrates what the structure enables. Small is not a materials characterization journal.

The bar is whether the paper shows what the nano- or microscale structure does beyond existing alternatives, in a device, sensor, catalytic, or biological context where the function is measured and compared. Synthesis papers where the advance is a new morphology without functional testing are consistently returned for additional experiments at Small.

Biological or chemistry paper with nano framing. The failure pattern is a paper whose primary content is a drug delivery assay, a catalytic cycle study, or a photochemical reaction mechanism, where nanoparticles appear as the delivery vehicle or catalyst support without being studied as the nano contribution.

Editors at Small identify papers where the chemistry or biology is the story and the nano component is the enabler rather than the subject. A drug delivery paper demonstrating cellular uptake and cytotoxicity using nanoparticle carriers, where the carrier formulation is the method rather than the finding, belongs at a pharmacology or biomedical journal.

A Small nanoscale contribution and functional demonstration check can assess whether the nanoscale angle is genuinely driving the science before the manuscript enters the review queue.

The 31% rate is most useful when you separate Small's two filters. The first filter is editorial: does the title, abstract, figure set, and cover letter make the nano or micro contribution obvious? The second filter is reviewer-facing: do the controls prove that the size-dependent mechanism, not just the material label, drives the result?

For authors, the operational question is not whether 31% sounds high or low. It is whether the editor can see a Small-shaped nano or micro contribution from the title, abstract, figures, and cover letter before the paper ever reaches reviewers.

If you are considering Small, these specific steps improve your chances:

• Lead with the size-driven advance. The first paragraph of the abstract should state what the nano or micro dimension changes, not just how the material was synthesized.

• Check the Small family fit. Read recent Small papers and adjacent titles such as Small Methods, Small Structures, and Small Science before deciding which Wiley nano venue owns the manuscript.

• Include a cover letter that addresses fit. Name the specific reason this paper belongs at Small rather than a competitor.

• Make the evidence package visible. Put the decisive TEM, XPS, biological-control, electrochemical, device, or stability evidence where the editor can see it quickly.

• Check article-type details. Wiley's author guidelines include optional author biographies of up to 100 words; small package details like this are not the main decision factor, but they signal whether the submission was prepared against the actual journal instructions.

For Small, authors should expect:

These ranges are planning estimates for a selective nanoscience journal. A paper with a clean scope fit can move faster than a paper whose editor first has to decide whether the nano component is the contribution or merely the vehicle.

Recent Small examples show the journal's breadth: atomically precise nanoclusters for light-activated microswimmers (DOI 10.1002/smll.202411517), defect-rich porous carbon nanosheets for lithium-ion storage and oxygen electrocatalysis (DOI 10.1002/smll.202503758), and hybrid ultrathin gold nanowire gels (DOI 10.1002/smll.202411506). The common thread is not one subfield; it is a nano- or microscale mechanism with a measurable functional consequence.

The acceptance rate does not tell you which Small submissions were rejected because the nano claim was cosmetic, which were rejected after review because controls were incomplete, or which were transferred into a better-fitting Wiley nano title. Those are the distinctions authors actually need before choosing the journal.

The 31% rate cannot tell you whether your manuscript belongs in Small. A paper with clear nanoscale fit, complete data, and a convincing function story has a different risk profile from a paper that uses nano language while the real contribution sits in chemistry, biology, or device engineering.

Before submitting, a Small nanoscale contribution, functional demonstration, and desk-rejection risk check can identify the specific issues that trigger desk rejection at Small before you commit to this target.

You can also review example reports before you finalize.

1. Is my paper ready for Small, Manusights.

1. Small vs Nano Letters, Manusights.